首页 研究 调查 数据 调研 战略 供需 策略 专项 现状 风险 运营 监测 深度 竞争 发展 专题 评估 动态 规划 咨询 投资 市场 分析 前景 预测 原创 行业 盈利 评价 经营 规模 观点 展望 前瞻 效益 服务 企业 渠道 细分 区域 投机 企业 生产 趋势 格局 销售 技术 状况 经销 环境 财务 风投 供应 产品 产销 商机 项目 能力 新闻
报告检索
您当前的位置:首页 > 规划报告 > 正文

2018-2025 Chinas pharmaceutical circulation industry research report

2018-2025 Chinas pharmaceutical circulation industry research report

郑重声明

特别声明:以下报告是由亚泰中研公司权威发布,尽可放心购买。

(北京亚泰中研咨询公司):我公司对所有研究报告产品拥有唯一著作权,公司从未通过任何第三方进行代理销售。亚泰中研是中国拥有研究人员数量最多、规模最大、实力最强的咨询研究机构,报告目录与内容未经亚泰中研公司事先书面许可,拒绝任何方式复制、转载。

  本文章共20928字,分3页,当前第1页,快速翻页:123 (code A000435 below the report is issued by the authority of yatai zhongyan company, please feel free to buy
Price: RMB 6,500 (text version)
Price: RMB 6800 (electronic version)
Price: RMB 7,500 yuan (full set)
Price: 6000 USD
Research direction: market research report
Date of publication: the latest publication authority
[content of the report] : text analysis data comparison and statistical chart
Within 2 working days
Delivery method: speedpost/sf express /
Liu Yang/zhang ke/liu Dan
[order telephone] : 010-57302159/13051511061
Green channel: 13051511061/15600031156
[report website] : http://www.yzyjbg.net http://www.zgcysddy.com/
[report name] :2018-2025 analysis report on the status of Chinas pharmaceutical circulation industry
Key words: circulation of medicine
Report catalog
Report catalog
Chapter 1 overview of pharmaceutical circulation 16
1.1 introduction to pharmaceutical circulation
1.1.1 Chinas pharmaceutical distribution link 16
1.1.2 business model of pharmaceutical circulation
1.1.3 four types of pharmaceutical middlemen 17
1.2 analysis of pharmaceutical circulation characteristics 21
1.2.1 characteristics of drug circulation
1.2.2 types of pharmaceutical circulation enterprises
1.2.3 channels for drug distribution
Chapter ii analysis of the development of pharmaceutical circulation industry in major countries in the world 30
2.1 analysis on the access system of foreign major national drug circulation 30
2.1.1 us drug distribution access system 30
2.1.2 Canadian drug distribution access system 31
2.1.3 UK drug distribution access system 31
2.1.4 Japans drug distribution access system 31
2.1.5 Indias access system for drug distribution 32
2.2 analysis of typical foreign drug distribution system
2.2.1 mature and complete drug distribution system in the United States
2.2.2 marketization of American pharmaceutical circulation 37
2.2.3 Japans drug distribution system 38
Japan pharmaceutical circulation industry chain 39
2.3 characteristics analysis of foreign major national drug distribution industries
2.3.1 high market concentration 41
2.3.2 retail pharmacy is the main channel 41
2.3.3 modern logistics system 41
2.3.4 attach importance to drug circulation safety 42
2.3.5 market intermediary specialization 42
2.3.6 rapid development of medical e-commerce 43
Chapter iii analysis on the development environment of Chinas pharmaceutical circulation industry 44
3.1 policy environment analysis of the development of Chinas pharmaceutical circulation industry in the past three years
3.1.12004 administrative measures on drug distribution license
3.1.22007 interpretation of new measures for the supervision and administration of drug circulation 44
3.1.3 China officially launched the establishment of a national basic drug system 47
3.1.4 analysis of the impact of centralized drug purchase policy in medical institutions
3.1.5 impact analysis of logistics industry revitalization plan on pharmaceutical logistics industry by 50
3.1.6 impact analysis of the new medical reform on the pharmaceutical logistics industry
3.1.7 analysis of administration work of drug circulation industry of ministry of commerce
3.1.8 Chinas drug recall system has been continuously improved in recent years
3.1.9 Chinas drug market regulation system 56
3.2 analysis of economic environment for the development of Chinas pharmaceutical circulation industry
3.2.1 analysis of the growth of Chinas P
3.2.2 analysis of Chinese residents income and consumption
3.2.3 Chinas population and composition statistics 62
3.2.4 degree macroeconomic operation analysis 62
3.3 social environment analysis of the development of Chinas pharmaceutical circulation industry 63
3.3.1 increase health awareness of Chinese residents 63
3.3.2 China has entered an aging society
3.3.3 the expansion of drug market brought by the national medical insurance
3.3.4 the Chinese government has increased its investment in medical and health care
3.4 technical environment analysis of the development of Chinas pharmaceutical circulation industry
3.4.1 the construction of e-commerce promotes the innovation of medical circulation system
3.4.2 application of electronic tags in pharmaceutical circulation industry
Chapter iv development analysis of Chinese pharmaceutical industry 72
4.1 global pharmaceutical industry development overview
4.1.1 status analysis of the global pharmaceutical industry
4.1.2 global drug sales volume and market size analysis 73
4.2 analysis of the development status of Chinas pharmaceutical industry
4.2.1 analysis of the impact of the new medical reform on the pharmaceutical industry
4.2.22013- analysis of medical industry economic operation and development 78
4.2.3 output analysis of major Chinese pharmaceutical products
4.2.4 public hospital reform has a profound impact on the pharmaceutical circulation industry
4.2.5 the NDRC re-adjusted the list of priced drugs 88
4.2.6 analysis of the effect of rational drug use in national formulary 88
4.3 foreign trade analysis of Chinas pharmaceutical industry
4.3.1 analysis of foreign trade operation in Chinas pharmaceutical industry
4.3.2 characteristics of Chinas pharmaceutical and foreign trade 92
4.3.3 multinational pharmaceutical companies speed up their expansion in China by 95
4.3.4 Chinas pharmaceutical trade frictions
4.3.5 analysis on the development trend of Chinas pharmaceutical trade
Chapter 5 analysis of the current situation of Chinas pharmaceutical circulation industry 98
5.1 analysis of current situation of Chinas pharmaceutical circulation industry
5.1.1 scale analysis of Chinas pharmaceutical circulation industry
5.1.2 Chinas pharmaceutical circulation industry integration accelerated 101
5.1.3 analysis of the development characteristics of Chinas pharmaceutical circulation industry
5.1.4 China will speed up the efficiency of pharmaceutical commercial circulation 104
5.1.5 traditional business format of pharmaceutical distribution is challenged 105
5.2 analysis on the development of Chinas pharmaceutical circulation channel 105
5.2.1 evolution history of Chinas pharmaceutical circulation channel 105
5.2.2 analysis of current situation of Chinas pharmaceutical circulation channel in recent years
5.2.3 analysis of influencing ctors of pharmaceutical circulation channels 110
5.3 profit flow and profit model analysis of Chinas pharmaceutical circulation
5.3.1 analysis on the flow direction of Chinas pharmaceutical circulation interests
5.3.2 analysis of major profit sources of Chinas pharmaceutical circulation industry
5.3.3 emerging profit model of Chinas pharmaceutical circulation industry
5.4 analysis on the competitive characteristics of Chinese pharmaceutical logistics market segment 115
5.4.1 competition pattern of three types of business
5.4.2 monopoly competition analysis of national pharmaceutical distribution 116
5.4.3 monopoly competition analysis of pharmaceutical distribution in three regions 116
5.4.4 oligopoly analysis of first-level distribution of special drugs 118
5.4.5 complete competition status analysis of pharmaceutical retail industry 119
5.5 problems existing in Chinas pharmaceutical circulation industry and development countermeasures 120
5.5.1 problems existing in Chinas drug distribution industry
5.5.2 problems in Chinas pharmaceutical circulation channels and Suggestions for development 122
5.5.3 change direction and development proposal of Chinas pharmaceutical circulation industry 125
5.5.4 analysis of the necessity of establishing a modern pharmaceutical circulation system in China 125
5.5.5 establishment of Chinas modern pharmaceutical circulation system 126
Chapter vi analysis of operational dynamics of Chinas pharmaceutical circulation enterprises 129
6.1 analysis of Chinas top 100 pharmaceutical circulation enterprises
6.1.1 overall situation analysis of Chinas top 100 pharmaceutical circulation enterprises
6.1.2 analysis of operation characteristics of top 100 enterprises in Chinas pharmaceutical circulation industry
6.1.3 analysis of ctors driving the growth of Chinas pharmaceutical circulation enterprises 135
6.2 analysis on the integration status of Chinese pharmaceutical logistics enterprises 137
6.2.1. Overview of operation of Chinas pharmaceutical circulation enterprises
6.2.2 large pharmaceutical logistics enterprises enjoy a sound development of 139
6.2.3 small and medium-sized pharmaceutical logistics enterprises are cing transformation 139
6.2.4 development trend of Chinas third-class pharmaceutical circulation enterprises 139
6.2.5 pharmaceutical commercial integration trend of central enterprises 141
6.3 typical models of Chinese pharmaceutical logistics enterprises are introduced in 143
6.3.1 self-operation mode of sinopharm logistics
6.3.2 the outsourced logistics mode of conenberg is 144
6.3.3 Beijing jinxiang pharmacys self-outsourcing hybrid model 145
6.3.4 hybrid model of Shanghai self-operation and external combination 145
6.4 analysis of problems and development strategies in Chinas pharmaceutical circulation enterprises
6.4.1 problems in logistics of pharmaceutical logistics enterprises
6.4.2 development strategy of Chinas pharmaceutical circulation enterprises under the new medical reform
6.4.3 Suggestions for positioning Chinese pharmaceutical logistics enterprises 149
6.4.4 analysis of development strategies of medium and small pharmaceutical circulation enterprises 152
6.4.5 Chinas pharmaceutical circulation enterprises should strengthen the drug recall system 155
Chapter vii development analysis of Chinas pharmaceutical wholesale industry 157
7.1 related overview of pharmaceutical wholesalers 157
7.1.1 definition of pharmaceutical wholesalers 157
7.1.2 the role of pharmaceutical wholesalers 157
7.2 analysis of the development status of Chinas pharmaceutical wholesale industry
7.2.1 three major changes of Chinas pharmaceutical wholesale enterprises 159
7.2.2 status of pharmaceutical commercial wholesale enterprise alliance
7.2.3 Chinas pharmaceutical wholesale enterprises accelerate the integration of 163
7.2.4 the new situation of Chinas pharmaceutical wholesale market 164
7.3 logistics transformation analysis of Chinese pharmaceutical wholesale enterprises 166
7.3.1 transformation of wholesale logistics integration of pharmaceutical enterprises
7.3.2 problems in logistics links of traditional pharmaceutical wholesale enterprises 168
7.3.3 planning and design of logistics distribution center of pharmaceutical wholesale enterprises
7.3.4 typical cases of applying modern logistics technology to pharmaceutical approved enterprises
7.4 analysis of the concentration of Chinas pharmaceutical wholesale industry 174
7.4.1 Chinas pharmaceutical wholesale industry has a low concentration of 174
7.4.2 analysis of 174 pharmaceutical wholesale modes in Chinas public hospitals
7.4.3 analysis of pharmaceutical wholesale distribution mode in Chinas retail market
7.4.4 ctor analysis of low concentration of Chinese pharmaceutical wholesales 179
7.4.5 strategic analysis of Chinas pharmaceutical wholesale towards moderate concentration
7.4.6 implementation of zero-rate sales of basic drugs across China
7.4.7 guangdong drug system implementation measures 183
7.5 analysis on the development strategy of Chinas wholesale industry
7.5.1 accurate positioning of drug wholesalers at 187
7.5.2 development strategy of small and medium-sized pharmaceutical wholesale enterprises under the new medical reform
7.5.3 analysis of the importance of developing modern logistics in pharmaceutical wholesale enterprises 189
7.5.4 Suggestions on developing modern logistics for pharmaceutical wholesale enterprises
7.5.5 coping strategies of Chinese pharmaceutical distribution companies
Chapter 8 development analysis of Chinas pharmaceutical agent industry 193
8.1 related overview of pharmaceutical agency system 193
8.1.1 definition of pharmaceutical agency system 193
8.1.2 classification of pharmaceutical agent system 194
8.1.3 characteristics of the pharmaceutical agent system 196
8.2 development history and trend of Chinas pharmaceutical agency system 197
8.2.1 bud stage 197
8.2.2 exploration stage
8.2.3 rapid development stage 199
8.2.4 mature stage 200
8.2.5 integration stage 201
8.3 analysis of the development status of Chinas pharmaceutical agent industry 202
8.3.1 Chinese pharmaceutical agents ce transformation 202
8.3.2 Chinas pharmaceutical agent bond shareholding pilot 203
8.3.3 analysis of development trend of Chinas pharmaceutical agent industry 204
8.4 analysis of development strategies for Chinas pharmaceutical agent industry
8.4.1 analysis of problems existing in Chinas pharmaceutical agency system
8.4.2 sustainable development analysis of Chinas pharmaceutical agency system 207
8.4.3 development strategy of Chinese pharmaceutical agents 209
8.4.4 refined management of Chinese pharmaceutical agents 213
Chapter 9 development analysis of Chinas pharmaceutical retail industry 217
9.1 China retail pharmacy expansion route analysis 217
9.1.1 analysis of chain-linked expansion route 217
9.1.2 analysis of branding expansion route 222
9.2 the development status of Chinas pharmaceutical retail industry in the past three years is 226
9.2.1 analysis of Chinas pharmaceutical retail market size
9.2.2 analysis of Chinese pharmacy retail market size
9.2.3 impact analysis of the new medical reform on Chinas pharmaceutical retail industry
9.2.4 analysis of diversified operation status of Chinese pharmacies
9.2.52013- financing and listing become industry hot spot 229
9.2.6 Chinas drug retail has a large regional difference of 231
9.3 analysis of operation status of top 100 Chinese drugstores
9.3.1 analysis on the sales scale of top 100 Chinese pharmacies
9.3.2 Chinas top 100 drugstores
9.3.3 pharmacy sales industry concentration analysis of 235
9.3.4 statistics of the number of top 100 drugstores in China
9.3.5 Chinas top 100 drugstores fixed-point rate analysis 237
9.3.6 overall profitability analysis of top 100 Chinese pharmacies
9.3.7 Chinas top 100 drugstores enterprise profitability analysis 239
9.3.8 profit analysis of top 100 Chinese drugstores 241
9.4 investigation and analysis of drug distribution channels in China
9.4.1 Chinas drugs are mainly sold through retail channels
9.4.2 the status of community hospitals in pharmaceutical sales increased by 246
9.4.3 survey and analysis of consumers drug purchase behavior in community hospitals 247
9.5 analysis of development status of Chinese online pharmacies
9.5.1 analysis of the development history of online pharmacies in China
9.5.2 analysis of Chinese online pharmacy business model 250
9.5.3 China online pharmacy alliance established 252
9.5.4 online payment of medical insurance card is expected to become the mainstream 252 in the future
9.6 analysis on the development status of pharmacy business alliances across China
9.6.1 Chinas drugstore product purchasing alliance has emerged 254
9.6.2 there are four types of 256 in China retail commercial alliance
9.6.3 analysis of the survival status of China pharmacy alliance 本文章更多内容: 1 - 2 - 3 - 下一页>>

2018-2025 Chinas pharmaceutical circulation industry research report
订购电话:010-57302178 010-57302159
绿色通道:13051511061 15600031156(24小时服务)

报告价值

  本报告由亚泰中研制作出版,是您全面深入了解该产业发展状况及投资机会的最佳参考工具。亚泰中研是中国领先产业研究与投资咨询机构,经过十多年时间的发展,亚泰中研已经构建了自有调查渠道包括网络、官方数据库、上市公司、调查公司、研究院、政府部门、行业协会、国外权威研究机构等在内的多渠道、多层面的数据来源;建立了包括国际国内上百个行业的千万级的数据库;形成了多种专业分析模型和研究方法;拥有近百名专业的行业分析师咨询师和业内专家。这些都是亚泰中研产品和服务专业性的有效保证。目前亚泰中研业务范围主要覆盖了细分产业研究、产业分析、市场现状、销售价格、前景展望、战略规划、未来预测、市场调查、市场调研、可行性分析与可行性研究等、商业计划书、营销策划、IPO咨询、专项市场解决方案、产业/园区规划、企业发展战略规划、数据库营销服务等以及为满足企业学习和提升经营能力的世界级经营管理智慧,我们已经成为一家多层次、多维度的综合性投资咨询机构。十多年来,亚泰中研已经为数万家包括政府机构、银行、研究所、行业协会、咨询公司、集团公司和各类投资公司在内的单位提供了专业咨询、信息咨询及研究报告、调查报告服务,并得到客户的广泛认可。

报告价值

· 该行业有多大市场规模?发展前景如何?值不值得投资?

· 市场细分和企业定位是否准确?主要客户群在哪里?营销手段有哪些?

· 您与竞争对手企业的差距在哪里?竞争对手的战略意图在哪里?

· 保持领先或者超越对手的战略和战术有哪些?会有哪些优劣势和挑战?

· 该行业的最新变化有哪些?市场有哪些新的发展机遇与投资机会?

· 该行业发展大趋势是什么?您应该如何把握大趋势并从中获得商业利润?

· 该行业内的成功案例、准入门槛、发展瓶颈、赢利模式、退出机制……

· 进入该行业需要了解哪些信息风险?原材料压力、政策和体制风险分析 ?

· 国内市前景预测,国际市前景预测、行业存在问题及对策解决?

数据支持

· 权威数据:国家统计局、国家信息中心、国家税务总局、国家工商总局、国务院发展研究中心、国家海关总署、全国商业信息中心、商务部研究院、清华大学图书馆、国家图书馆、全国200多个行业协会、行业研究所、海外产业研究机构等上万种专业信息来源。

· 亚泰中研自主研发数据库:亚泰中研细分行业数据库、亚泰中研上市公司数据库、亚泰中研非上市企业数据库、宏观经济数据库、区域经济数据库、产品产销数据库、产品进出口数据库。

· 最新一手数据:遍布全国32个省市业内专家顾问网络,涉及政府统计部门、统计机构、生产厂商、销售商、下游需求商、地方主管部门以及在华投资机构。在中国,亚泰中研咨询拥有最大的数据搜集网络数据库,在研究项目最多的一线城市设立了办事处,并在超过50多个城市建立了操作地,资料搜集的工作已覆盖200个地区。

研发流程

研发流程定制报告

· 步骤1:设立研究小组,确定研究内容

· 步骤2:市场总量调研

· 步骤3:市场占有率调查

· 步骤4:企业产销量上下游调查

· 步骤5:核实来自各方信息渠道的数据与基础资料整理

· 步骤6:进行数据建模分析研究并起草初步研究框架

· 步骤7:专家访谈、审阅并提出意见与建议

· 步骤8:分析师系统分析并撰写最终最新报告
(对行业盈利点、增长点、机会点、预测点等进行系统分析并完成报告)

· 步骤9:客户反馈跟进与售后服务
(对用户提出的有关问题给予免费解答;了解客户反馈,并就有关问题进行深入调查和项目咨询)

热点关注
2019-2025年中国牵引拖车行业调研报告

2019-2025年中国牵引拖车行业调研报告

第一章 牵引拖车行业发展概述 第一节牵引拖车行业定义 一、牵引拖车定义 二、牵引拖车应用 第二节牵引拖车行业发展概况 一、全球牵引拖车行

最新报告

热销排行榜

今日

本周

本月